{"entity":{"type":"insider","cik":"0001448434","url":"/insider/0001448434","json_url":"/insider/0001448434.json","name":"Keane Raymond T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":14,"first":"2010-05-19","last":"2013-07-18","span_basis":"filed_date"},"name_variants":[{"name":"Keane Raymond T","source":"filing","n_filings":14,"first_seen":"2010-05-19","last_seen":"2013-07-18"}],"transactions":[{"id":5246476,"accession":"0001127602-13-023097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-13-023097","line_url":"/filing/0001127602-13-023097#line-1","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":19.7858,"price_display":"19.79","price_state":"stated","total_value":158286.4,"total_display":"158,286.40","total_whole":"158,286","shares_owned_after":62096.0,"shares_owned_after_display":"62,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-18","filed_date":"2013-07-18","scope":"insider"},{"id":5475787,"accession":"0001127602-13-013315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-013315","line_url":"/filing/0001127602-13-013315#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2583.0,"shares_display":"2,583","price_per_share":18.0509,"price_display":"18.05","price_state":"stated","total_value":46625.4747,"total_display":"46,625.47","total_whole":"46,625","shares_owned_after":54096.0,"shares_owned_after_display":"54,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-03","scope":"insider"},{"id":4399063,"accession":"0001127602-13-012016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-012016","line_url":"/filing/0001127602-13-012016#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13167.0,"shares_display":"13,167","price_per_share":18.8716,"price_display":"18.87","price_state":"stated","total_value":248482.3572,"total_display":"248,482.36","total_whole":"248,482","shares_owned_after":51513.0,"shares_owned_after_display":"51,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-26","scope":"insider"},{"id":5118422,"accession":"0001127602-13-011841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-011841","line_url":"/filing/0001127602-13-011841#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2334.0,"shares_display":"2,334","price_per_share":19.4613,"price_display":"19.46","price_state":"stated","total_value":45422.6742,"total_display":"45,422.67","total_whole":"45,423","shares_owned_after":38347.0,"shares_owned_after_display":"38,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-22","filed_date":"2013-03-22","scope":"insider"},{"id":3167463,"accession":"0001127602-12-025966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-025966","line_url":"/filing/0001127602-12-025966#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":220000.0,"total_display":"220,000.00","total_whole":"220,000","shares_owned_after":31500.0,"shares_owned_after_display":"31,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-06","filed_date":"2012-09-07","scope":"insider"},{"id":2736347,"accession":"0001127602-12-025777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-025777","line_url":"/filing/0001127602-12-025777#line-1","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7780.0,"shares_display":"7,780","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":163380.0,"total_display":"163,380.00","total_whole":"163,380","shares_owned_after":31500.0,"shares_owned_after_display":"31,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-04","filed_date":"2012-09-05","scope":"insider"},{"id":3367216,"accession":"0001127602-12-024598","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-024598","line_url":"/filing/0001127602-12-024598#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":39280.0,"shares_owned_after_display":"39,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-15","filed_date":"2012-08-16","scope":"insider"},{"id":2735889,"accession":"0001127602-12-023386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-023386","line_url":"/filing/0001127602-12-023386#line-1","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":190000.0,"total_display":"190,000.00","total_whole":"190,000","shares_owned_after":39280.0,"shares_owned_after_display":"39,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-30","filed_date":"2012-08-01","scope":"insider"},{"id":2550372,"accession":"0001127602-12-023009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-023009","line_url":"/filing/0001127602-12-023009#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":49280.0,"shares_owned_after_display":"49,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-26","filed_date":"2012-07-27","scope":"insider"},{"id":2944926,"accession":"0001127602-12-013032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-013032","line_url":"/filing/0001127602-12-013032#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2067.0,"shares_display":"2,067","price_per_share":16.1853,"price_display":"16.19","price_state":"stated","total_value":33455.0151,"total_display":"33,455.02","total_whole":"33,455","shares_owned_after":48980.0,"shares_owned_after_display":"48,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-03","filed_date":"2012-04-03","scope":"insider"},{"id":3520415,"accession":"0001127602-12-011830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-011830","line_url":"/filing/0001127602-12-011830#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10533.0,"shares_display":"10,533","price_per_share":15.406,"price_display":"15.41","price_state":"stated","total_value":162271.398,"total_display":"162,271.40","total_whole":"162,271","shares_owned_after":45880.0,"shares_owned_after_display":"45,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-26","scope":"insider"},{"id":2733539,"accession":"0001127602-12-011603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-011603","line_url":"/filing/0001127602-12-011603#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":15.0184,"price_display":"15.02","price_state":"stated","total_value":126154.56,"total_display":"126,154.56","total_whole":"126,155","shares_owned_after":30380.0,"shares_owned_after_display":"30,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-20","filed_date":"2012-03-21","scope":"insider"},{"id":2484273,"accession":"0001127602-12-006383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-006383","line_url":"/filing/0001127602-12-006383#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":15.1342,"price_display":"15.13","price_state":"stated","total_value":189177.5,"total_display":"189,177.50","total_whole":"189,178","shares_owned_after":17780.0,"shares_owned_after_display":"17,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-14","filed_date":"2012-02-16","scope":"insider"},{"id":7503485,"accession":"0001140361-10-022270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-022270","line_url":"/filing/0001140361-10-022270#line-1","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001448434","owner_name":"Keane Raymond T","owner_display_name":"Keane Raymond T","owner_url":"/insider/0001448434","role":"Officer (SVP General Counsel & CCO)","role_mark":"O","role_mark_label":"Officer (SVP General Counsel & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP General Counsel & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10256.0,"shares_display":"10,256","price_per_share":4.09,"price_display":"4.09","price_state":"stated","total_value":41947.04,"total_display":"41,947.04","total_whole":"41,947","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-17","filed_date":"2010-05-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000884731","name":"ARIAD PHARMACEUTICALS INC","url":"/issuer/0000884731","role":"Officer (SVP General Counsel & CCO)","n_filings":14,"first_seen":"2010-05-19","last_seen":"2013-07-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001448434","retrieved_at":"2026-08-23T07:38:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}